Brands

Johnson & Johnson Vision, leader in eye health,introduces its latest innovation, ACUVUE^® OASYS MAX 1-Day contact lenses and ACUVUE^® OASYS MAX 1-Day MULTIFOCAL contact lenses for presbyopia

Designed to meet the increased daily demands on our eyes, the new contact lenses feature an unprecedented combination of two new technologies: TearStable^TM and OptiBlue^TM.¹

TearStable^TM technology maximizes tear film stability and locks out moisture¹ for exceptional all- day comfort.² OptiBlue^TM Light Filter features the highest level of blue-violet light protection by 60% in the industry¹ , ** , † helping to reduce light scatter and increase visual clarity, both day and night.² In addition, ACUVUE^® OASYS MAX 1-DAY contact lenses blocks 99.9% of UVA and 100% of UVB rays. ¹,^‡‡

ACUVUE^®, OASYS MAX 1-Day contact lenses are available in spherical and multifocal lenses and come as a result of global research that finds that nowadays the amount of time spent in front of digital screens has increased dramatically compared to the years before the pandemic.³

For patients with presbyopia, ACUVUE^® OASYS MAX 1-Day MULTIFOCAL contact lenses, provide crisp, clear vision at all distances and in all light conditions - and all-day comfort.⁴ They combine the same innovative technologies, TearStable^TM Technology and OptiBlue^TM Light Filter with the unique Pupil Optimization Design, adapting 100% of the parameters to the natural variation of pupil size according to age and refractive error, for a superior vision experience. ⁴,⁵,^***

ACUVUE^® OASYS MAX 1-Day and ACUVUE^® OASYS MAX 1-Day MULTIFOCAL contact lenses, belong to ACUVUE^® OASYS family, the contact lenses which are unbeaten in comfort in more than 47 clinical trials. ^‡‡‡

According to research for ACUVUE^® OASYS MAX 1-Day, more than 90% of wearers, reported to see comfortably all day and were more likely to report the ability to see comfortably when using digital devices, plus, almost 100% agreed that the lenses provided clear and reliable vision.²

Important Safety Information:

ACUVUE^® contact lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed information, including warnings and precautions, carefully read the Instructions for Use available on Johnson & Johnson website (www.e-IFU.com).

^†HeV light filtering by contact lenses has not been shown to provide any benefit to the wearer's systemic and/or ocular health. For more information you should consult an eye health professional.

^** Compared to available published information on typical daily contact lens wear from July 2023.

^‡‡ All ACUVUE^®  contact lenses have Class 1 or Class 2 UV Blocking to help provide protection against transmission of harmful UV radiation to the cornea and into the eye. UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. UV transmission measured with -1.00 lens.

^*** Compared to competitor designs, the technology was optimized for both refractive error parameters and power of the add

^‡‡‡ Clinical trial results posted on www.clinicaltrials.gov, a website maintained by ΝΙΗ, were reviewed as of April 30,2024. The 47 clinical trials evaluated subjective comfort as a primary or secondary endpoint for the ACUVUE^® OASYS Brand Family (including daily disposable families), the 1-DAY ACUVUE^® MOIST Brand family (within the category of hydrogel daily disposable), and the ACUVUE^® VITA Brand family, vs. competitors’ products.

1 JJV Data on File 2022. Definition of TearStable^TM  technology. 2 JJV Data on File. CSM Subjective Responses to ACUVUE^®  OASYS MAX 1-Day Contact Lenses– Exploratory Meta-Analysis. 3 Research for digital comfort, March 2022, TRUE Global Intelligence and Vitreous World. 4 JJV Data on File. CSM Subjective Responses to ACUVUE^® OASYS MAX 1-Day Contact Lenses– Exploratory Meta-Analysis. 5 JJV Data on file 2022. - ACUVUE^® PUPIL OPTIMIZED DESIGN Technology: JJVC contact lenses, design features and associated benefits.

ACUVUE^® , ACUVUE^® OASYS MAX 1-Day, ACUVUE^® OASYS MAX 1-Day MULTIFOCAL, TearStable^ΤΜ and OptiBlue^ΤΜ are registered trademarks of Johnson & Johnson, Johnson & Johnson, 2024.